| | | | We’ve announced a £173m investment in the Cancer Research UK Cambridge Institute, following its successful funding review earlier this year. This is the largest single grant we have ever awarded outside of London, positioning the institute as a world leader in cancer research.
Over the next seven years, the funding will support the institute’s 300+ researchers in programmes of fundamental discovery science and clinical translational research. Established in 2007, the institute was the UK’s first major new cancer research centre for over 50 years, and the funding will enable researchers to continue to uncover new insights into how cancers develop, grow and spread.
“In a golden era for life sciences, this funding bolsters Cambridge as a major global hub for cancer research on an increasingly competitive worldwide stage and will greatly aid the recruitment of top-tier international talent,” says Greg Hannon, Director of our Cambridge Institute.
“Research from the institute has already made a positive impact for patients and their families, from the development of innovative technologies, diagnostic tests and advanced imaging methods to the roll out of personalised medicine programmes for those with brain, breast, pancreatic, and ovarian cancers.
“We believe that only by embracing the complexity of cancer and how the disease interacts with the normal cells of patients can we move the needle on the hardest to treat cancers.” |
| | |
| | |
|
|
|
|
